Patrick D. Yeramian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 2,034 shares at $36.79 ($74K) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Scheduled sale ($74k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.08 | 1,405 | $51K | 68.7% |
| 2 | $36.79 | 629 | $23K | 31.3% |
| Total | $36.30 avg | 2,034 | $74K | 100% |
| Filing → |
| AMLX | SELL | 2023-04-19 | $3.0M | — | Filing → |
| AMLX | SELL | 2023-03-24 | $3.5M | — | Filing → |